Enabling Novel MS-Based Methods for Characterization of Biopharmaceuticals Background The Merck Serono structural characterization laboratory in Guidonia is part of the Characterization and Innovative Analytics Unit of the Analytical Development Biotech Department. Our role is to advise and support Merck worldwide in the development and production of novel biopharmaceuticals by providing a comprehensive structural overview of drug molecules and supporting process development and validation through advanced characterization approaches. The ability to deliver information-rich data at a molecular level makes mass spectrometry (MS) the technology of choice for applications such as (glyco)peptide mapping, disulfide-bridge and intact-mass analysis, top-down sequencing, and released gly

Join for free to read